Group II Secretory PLA2: A New Cardiovascular Risk Factor

Publisher： Bentham Science Publishers

E-ISSN： 1875-614x|5|2|163-173

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.5, Iss.2, 2006-05, pp. : 163-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Group IIA Secretory PLA2 Inhibition by Ursolic Acid: A Potent Anti-Inflammatory Molecule

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-04 ,pp. : 801-809

Bentham Science Publishers

Access to resources Recommend Favorite

A New Emerging Risk Factor for Cardiovascular Disease: Apo(a) Polymorphism

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Crystal structure of the complex of group I PLA 2 with a group II-specific peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) at 2.6 Å resolution

By Singh Rajendra K.   Singh Nagendra   Jabeen Talat   Sharma Sujata   Dey Sharmistha   Singh T. P.  

Journal of Drug Targeting, Vol. 13, Iss. 6, 2005-07 ,pp. : 367-374

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Secretory Phospholipase A2 Group IIA

By  

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 3011-3026

Bentham Science Publishers

Access to resources Recommend Favorite

Homocysteine: A Risk Factor in Patietns with Cardiovascular Disorders in Pakistan

By  

Current Bioactive Compounds, Vol. 11, Iss. 4, 2015-12 ,pp. : 210-214

Bentham Science Publishers

Access to resources Recommend Favorite